Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danlu capsule + Huangkui capsule is a combination therapy of two traditional Chinese medicines being investigated for the treatment of granulomatous lobular mastitis. [19] Huangkui capsule, derived from the flower of Abelmoschus manihot, exerts anti-inflammatory, immunomodulatory, and antioxidant effects. [1, 3, 5] It is primarily used to treat chronic kidney diseases by reducing proteinuria and protecting renal function, but its anti-inflammatory properties are being leveraged for other conditions. [2, 4] Danlu capsule is a traditional formula containing ingredients such as deer antler (Lujiao), Salvia miltiorrhiza (Danshen), and others, which is used to promote blood circulation, resolve stasis, and alleviate pain, and is clinically used for breast hyperplasia. [7, 9, 10, 11] The combination therapy aims to treat granulomatous lobular mastitis, a chronic inflammatory breast disease, by synergistically reducing inflammation and improving microcirculation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on danlu capsule + huangkui capsule.